NOVOGEN DRUGS AND PHARMA PRIVATE LIMITED.

A Registered BIR is a comprehensive due diligence document built exclusively on statutory data. Unlike reports for unregistered firms, it aggregates official filings from the Ministry of Corporate Affairs (MCA), GSTN, and ROC for Private Limited, Public Limited, and LLP entities to provide a verified 'Source of Truth' for credit and risk assessment.

Traditional reports are often 'snapshots' that become obsolete the moment they are saved. Our product is a Live Data Layer. Instead of a static PDF, you access a dynamic engine that pulls real-time data from government portals, ensuring your risk policy is based on today’s filings, not six-month-old archives.

We provide a 360-degree view by aggregating data from: MCA21 for shareholding, director details, and charges; GSTN for tax filing discipline and turnover trends; Legal/Courts for stage-wise litigation tracking across District, High, and Supreme Courts; Default Lists including RBI Defaulters, SEBI debarred lists, and EPF data.

Yes. Our reports are engineered to meet the stringent KYB (Know Your Business) and PMLA (Prevention of Money Laundering Act) guidelines. They facilitate 'Perpetual KYC' by automatically flagging changes in directorship, shareholding, or legal status, helping BFSI institutions stay audit-ready.

Absolutely. Our product is built as a DaaS (Data as a Service) platform. You can access reports via our secure web portal or integrate our REST APIs directly into your Loan Origination System (LOS), ERP, or internal risk models for automated decisioning.

Yes. Using our Dynamic Report Architect, you can select from over 100+ data variables to build a format that matches your specific credit policy. You can remove irrelevant noise and standardize templates for your entire organization to ensure consistent risk evaluation.